Evidence map›Paper›PMID 30228274›Full record

ArticleNature communications2018

Author Correction: Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease.

Chen Yao, George Chen, Ci Song, Joshua Keefe, Michael Mendelson, Tianxiao Huan, Benjamin B Sun, Annika Laser, Joseph C Maranville, Hongsheng Wu and 14 more

Abstract readPublished Erratum
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Association ofFrontiers in cardiovascular medicine · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Chen YaoFramingham Heart Study, Framingham, 01702, MA, USA.ORCID http://orcid.org/0000-0002-3944-7788
George ChenFramingham Heart Study, Framingham, 01702, MA, USA.
Ci SongFramingham Heart Study, Framingham, 01702, MA, USA.
Joshua KeefeFramingham Heart Study, Framingham, 01702, MA, USA.
Michael MendelsonFramingham Heart Study, Framingham, 01702, MA, USA.
Tianxiao HuanFramingham Heart Study, Framingham, 01702, MA, USA.
Benjamin B SunMRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.ORCID http://orcid.org/0000-0001-6347-2281
Annika LaserResearch Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
Joseph C MaranvilleMRL, Merck & Co., Inc, Kenilworth, 07033, NJ, USA.
Hongsheng WuComputer Science and Networking, Wentworth Institute of Technology, Boston, 02115, MA, USA.
Jennifer E HoCardiovascular Research Center and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, 02114, MA, USA.
Paul CourchesneFramingham Heart Study, Framingham, 01702, MA, USA.
Asya LyassFramingham Heart Study, Framingham, 01702, MA, USA.
Martin G LarsonFramingham Heart Study, Framingham, 01702, MA, USA.
Christian GiegerResearch Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany.
Johannes GraumannScientific Service Group Biomolecular Mass Spectrometry, Max Planck Institute for Heart and Lung Research, W.G. Kerckhoff Institute, Ludwigstr. 43, D-61231, Bad Nauheim, Germany.ORCID http://orcid.org/0000-0002-3015-5850
Andrew D JohnsonFramingham Heart Study, Framingham, 01702, MA, USA.
John DaneshMRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.
Heiko RunzMRL, Merck & Co., Inc, Kenilworth, 07033, NJ, USA.
Shih-Jen HwangFramingham Heart Study, Framingham, 01702, MA, USA.
Chunyu LiuFramingham Heart Study, Framingham, 01702, MA, USA.
Adam S ButterworthMRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, CB1 8RN, UK.ORCID http://orcid.org/0000-0002-6915-9015
Karsten SuhreDepartment of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Education City, PO 24144, Doha, Qatar.ORCID http://orcid.org/0000-0001-9638-3912
Daniel LevyFramingham Heart Study, Framingham, 01702, MA, USA. levyd@nih.gov.

Funding

Framingham Project/LevyZIAHL006001 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEVY, DANIEL · 2009 to 2025
$51.1M
Circulating Epigenetic Biomarkers for Personalized Cardiovascular Disease PreventionK99HL136875 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI MENDELSON, MICHAEL MAXWELL · 2017 to 2018
$330k
Medical Research Council G0800270NHLBI NIH HHS K99 HL136875
6 · The paper itself

Abstract

In the originally published version of this Article, financial support was not fully acknowledged. The sentence "KS was supported by the 'Biomedical Research Program' funds at Weill Cornell Medicine in Qatar, a program funded by the Qatar Foundation" has been added to the acknowledgement section in both the PDF and HTML versions of the Article.

Identifiers

PMID30228274
PMCPMC6143533

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.